Related Experiment Videos
Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study
L J Fitten1, K M Perryman, P L Gross
1VA Medical Center, Sepulveda, Calif 91343.
The American Journal of Psychiatry
|February 1, 1990
Abstract:
Ten Alzheimer's disease patients underwent a trial of oral tetrahydroaminoacridine (THA) and lecithin. After 3 inpatient weeks there was no clear therapeutic effect. Three of six patients able to continue in long-term treatment showed measurable cognitive improvement, but only one displayed clinically obvious improvement.